US AI lobbying surge exposes corporate capture of policy, sidelining public interest and global equity
Original framing: “AI companies spend record sums on Washington lobbying” — Financial Times
Scientific literature documents how concentrated lobbying correlates with weaker safety standards and slower adoption of robust risk assessments in AI. Empirical studies on policy capture demonstrate that increased spending reduces the likelihood of precautionary regulation. The article neglects to cite this evidence, presenting lobbying as a neutral fact.
The record lobbying spend by US AI giants is not an isolated market maneuver but a continuation of historic regulatory capture that sidelines Indigenous, marginalised, and cross‑cultural perspectives.
Scientific evidence links such capture to weaker safety regimes, while future modelling warns of entrenched monopolies that exacerbate inequality. By foregrounding Indigenous data sovereignty, building public‑interest lobbying coalitions, and pursuing an international regulatory charter, we can re‑balance power, embed ethical safeguards, and prevent the commodification of democratic institutions. Actors ranging from civil society groups to intergovernmental bodies must coordinate to transform the current narrative from a profit‑centric arms race into a collaborative governance ecosystem.